A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2006
11/22/2006	CN1867552A Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
11/22/2006	CN1867550A Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders
11/22/2006	CN1867549A Cyclopropyl derivatives as NK3 receptor antagonists
11/22/2006	CN1867358A Combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression
11/22/2006	CN1867346A Plant part of opuntia and/or its extract in treatment of depression
11/22/2006	CN1867333A Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
11/22/2006	CN1867328A Treatment of neurodegenerative conditions
11/22/2006	CN1867324A Use of effectors of glutaminyl and glutamate cyclases
11/22/2006	CN1865450A Fatty acid extract of Antrodiacamphorata mycelium and its uses
11/22/2006	CN1865260A Long chain arylpiperazine modified duloxetine analog compound and preparation and uses
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1864748A Preparation of dopamine agonist and application thereof
11/22/2006	CN1864726A Powder dedicated to treating headache and preparation method thereof
11/22/2006	CN1864721A Chinese medicinal wine
11/22/2006	CN1864704A Herbal composition for treatment of arthritic disorders, skin inflammatory disorders and pain
11/22/2006	CN1864701A A Chinese medicinal membrane agent capable of being dissolved rapidly in oral cavity and preparation method thereof
11/22/2006	CN1864675A Use of naringenin and derivative in preparation of product for resisting cardiovascular and cerebrovascular disease
11/22/2006	CN1864663A Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2 (11),3,5,7,9-pentaene
11/22/2006	CN1864511A Method for preparing sober-up cream candy
11/22/2006	CN1285607C Chinese hard tick neuropeptide and its preparing method and use
11/22/2006	CN1285582C Thioflavin derivatives for alzheimer's disease premortal diagnosis and starch-like protein in vivo image forming and precaution
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285575C Heterocyclic thioesters and ketones
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285381C Chemokine mutants in treatment of multiple sclerosis
11/22/2006	CN1285335C Pyrithioxine hydrochloride freeze-dried composition and its preparing method
11/22/2006	CN1285334C Application of pinocembrin in preparing medication for treating disease relevant to hurt of nerve cell
11/21/2006	US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138499 antibody that binds to a peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily
11/21/2006	US7138492 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
11/21/2006	US7138427 Cognition activators
11/21/2006	US7138426 Estrogen receptor modulators
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138420 Substituted benzimidazole compounds
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138410 Aza-bicyclic N-biarylamides with affinity for the α7 nicotinic acetylcholine receptor
11/21/2006	US7138407 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138394 Vehicle for topical delivery of anti-inflammatory compounds
11/21/2006	US7138380 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
11/21/2006	US7138275 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/21/2006	US7138234 Gene involved in CADASIL, method of diagnosis and therapeutic application
11/21/2006	US7138117 Antigen-binding fragment or antibody which binds to a mammalian CC-chemokine receptor 4 (CCR4); medical diagosis, therapy, or prophylaxis; antiinflammatory agents
11/21/2006	CA2478621C Botulinum toxin pharmaceutical compositions
11/21/2006	CA2338753C Medicinal aerosol formulations
11/21/2006	CA2334718C Quinoline derivatives
11/21/2006	CA2302156C Methods for modulating the axonal outgrowth of central nervous system neurons
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/21/2006	CA2168022C Vasoconstrictive substituted dihydropyranopyridines
11/16/2006	WO2006122259A1 Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
11/16/2006	WO2006122255A1 Pregabalin free of isobutylglutaric acid and a process for preparation thereof
11/16/2006	WO2006121922A1 Monoamine re-uptake inhibitors and methods relating thereto
11/16/2006	WO2006121919A2 Methods of treating obsessive compulsive disorder
11/16/2006	WO2006121557A1 Pregabalin free of lactam and a process for preparation thereof
11/16/2006	WO2006121363A1 Eslicarbazepine acetate and methods of use
11/16/2006	WO2006121258A1 Composition comprising an obovatol having anti-anxiety activity
11/16/2006	WO2006121218A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	WO2006121104A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/16/2006	WO2006120575A2 Tcr-independent activation of t cells with co-lignation of cd28 and cd81
11/16/2006	WO2006120481A2 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1)
11/16/2006	WO2006120412A1 Pharmaceutical formulation of apomorphine for buccal administration
11/16/2006	WO2006119958A2 Use of flibanserin in the treatment of chronic pain
11/16/2006	WO2006119884A2 Method for the treatment of drug abuse with flibanserin
11/16/2006	WO2006119589A2 Prevention and therapy of cerebral folate deficiency
11/16/2006	WO2006105035A3 Muscarinic modulators
11/16/2006	WO2006083424A3 Radiolabeled compounds and uses thereof
11/16/2006	WO2005103047A8 Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof
11/16/2006	WO2002094236A9 Delivery of antipsychotics through an inhalation route
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258750 Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
11/16/2006	US20060258745 Deramciclane-fumarate tablets
11/16/2006	US20060258742 Hydroxy tetrahydro-naphthalenylurea derivatives
11/16/2006	US20060258734 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of Levetiracetam and analogues
11/16/2006	US20060258724 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents; Alzheimer's disease; anticancer agents
11/16/2006	US20060258707 Benzimidazolidinone derivatives as muscarinic agents
11/16/2006	US20060258704 2-Oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258701 glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus; 3-(4-methoxy-phenylsulfanyl)-6-(4H-[1,2,4]triazol-3-yl-sulfanyl)-N-([1,3,4]thiadiazol-2-yl)-2-pyridine carboxamide
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258678 Novel indole derivatives
11/16/2006	US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258654 Pyridinylmorpholine derivatives
11/16/2006	US20060258653 Derivatives of sulphonamides, their preparation and use as medicaments
11/16/2006	US20060258652 Beta-blockers having antioxidant and no-donor activity
11/16/2006	US20060258638 Succinoylamino lactams as inhibitors of A-beta protein production
11/16/2006	US20060258637 Fused polycyclic compounds
11/16/2006	US20060258598 Alpha-keto carbonyl calpain inhibitors
11/16/2006	US20060258563 Nitrogen Oxide scavenging ability; digesting cytochrome c with restriction enzyme; use in prophylactic and therapeutics, measuring/treating nitrogen oxide concentrations in air, exhaust gas or water
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257433 Formulation

1 ... 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 ... 1833